374 related articles for article (PubMed ID: 16752188)
1. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.
Shen WY; Lai CM; Graham CE; Binz N; Lai YK; Eade J; Guidolin D; Ribatti D; Dunlop SA; Rakoczy PE
Diabetologia; 2006 Jul; 49(7):1690-701. PubMed ID: 16752188
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
3. Generation of transgenic mice with mild and severe retinal neovascularisation.
Lai CM; Dunlop SA; May LA; Gorbatov M; Brankov M; Shen WY; Binz N; Lai YK; Graham CE; Barry CJ; Constable IJ; Beazley LD; Rakoczy EP
Br J Ophthalmol; 2005 Jul; 89(7):911-6. PubMed ID: 15965177
[TBL] [Abstract][Full Text] [Related]
4. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
5. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
7. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
9. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
10. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.
Miyamoto K; Khosrof S; Bursell SE; Rohan R; Murata T; Clermont AC; Aiello LP; Ogura Y; Adamis AP
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10836-41. PubMed ID: 10485912
[TBL] [Abstract][Full Text] [Related]
11. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.
Rakoczy PE; Brankov M; Fonceca A; Zaknich T; Rae BC; Lai CM
Diabetes; 2003 Mar; 52(3):857-63. PubMed ID: 12606531
[TBL] [Abstract][Full Text] [Related]
12. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
13. A central role for inflammation in the pathogenesis of diabetic retinopathy.
Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP
FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732
[TBL] [Abstract][Full Text] [Related]
14. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
16. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.
Wang J; Xu X; Elliott MH; Zhu M; Le YZ
Diabetes; 2010 Sep; 59(9):2297-305. PubMed ID: 20530741
[TBL] [Abstract][Full Text] [Related]
17. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
18. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
[TBL] [Abstract][Full Text] [Related]
19. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys.
Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO
Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
